Study Stopped
Technical problems
The Effect of Optic Flow During Treadmill Walking on the Gait Pattern in People Post-stroke
VR-enhanced Walking in People Post-stroke: the Effect of Changing the Optic Flow Speed During Treadmill Walking on the Gait Pattern
1 other identifier
interventional
2
1 country
1
Brief Summary
The aim of this study is to investigate the onset, magnitude and duration of the effect of manipulating the optic flow on the gait pattern during Virtual Reality (VR)-enhanced treadmill walking compared to treadmill walking without VR in people post-stroke.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable stroke
Started Nov 2019
Shorter than P25 for not_applicable stroke
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 26, 2019
CompletedFirst Posted
Study publicly available on registry
April 2, 2019
CompletedStudy Start
First participant enrolled
November 25, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 14, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 14, 2019
CompletedApril 7, 2020
April 1, 2020
19 days
March 26, 2019
April 3, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
3D kinematic measurements
Kinematic data of the lower limbs (i.e. movement amplitudes of the bilateral hip, knee and ankle joint) during treadmill walking will be recorder continuously.
Kinematic data will be measured continuously for 20 minutes and will be expressed per gait cycle
Spatiotemporal gait parameters
Spatiotemporal gait parameters of the lower limbs (i.e. walking speed, cadence, step length and - time, swing - and stance time, single - and double limb support period) during treadmill walking will be recorded continuously.
Spatiotemporal gait parameters will be measured continuously for 20 minutes and will be expressed per gait cycle
Muscle activity (EMG)
Muscle activity of the lower limb muscles (bilateral: M. rectus femoris, M. vastus medialis and lateralis, M. biceps femoris, M. tibialis anterior, M. gastrocnemius medialis and lateralis) will be recorded continuously during treadmill walking with the use of surface electrodes.
Muscle activity will be measured continuously for 20 minutes and will be expressed per gait cycle
Secondary Outcomes (3)
Simulator Sickness Questionnaire (SSQ)
The SSQ will be assessed twice per session (session 1 - 2 - 3 - 4): immediately before and after the participants walked for 20 minutes.
Physical Activity Enjoyment Scale (PACES)
The PACES will be assessed once per session (session 1 - 2 - 3 - 4): immediately after the participants walked for 20 minutes.
Number of falls or stumbles
The number of falls or stumbles will be assessed continuously for 20 minutes when patients are walking on the treadmill. The number of falls will be collected for each walking session (session 1 - 2 - 3 - 4).
Study Arms (1)
VR-enhanced treadmill walking
EXPERIMENTALParticipants will be tested during 4 sessions of 20 minutes treadmill walking.
Interventions
Patients will perform 4 sessions of 20 minutes treadmill walking: one control session without VR and 3 walking sessions with the VR. In each VR session, patients will walk with a different optic flow speed: the same as, faster than or slower than their walking speed.
Eligibility Criteria
You may qualify if:
- diagnosed with stroke (as defined by the World Health Organization)
- stroke onset ≥ 6 months
- ambulatory with an impaired gait pattern (FAC-score 2 or 3 or 4)
- ability to walk on a treadmill for 20 minutes without bodyweight support
- adult (≥ 18 years)
- a body height between 155 cm and 200 cm
- ability to signal pain, fear and discomfort
- ability to give informed consent
You may not qualify if:
- other neurological deficits than stroke leading to impaired gait
- comorbidities (e.g. COPD, osteoporosis, cardiovascular instability)
- visual and/or vestibular disorders that can interfere with the VR
- uncontrolled spasticity significantly interfering with the movement of the lower extremities (Modified Ashworth Scale \> 2)
- acute medical illness
- communicative/cognitive problems leading to the inability to understand and carry out instructions
- severe unilateral spatial neglect
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Vrije Universiteit Brussel
Brussels, 1050, Belgium
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Eva Swinnen, Prof. Ph.D
Vrije Universiteit Brussel
- STUDY CHAIR
Eric Kerckhofs, Prof. Ph.D
Vrije Universiteit Brussel
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctoral Researcher
Study Record Dates
First Submitted
March 26, 2019
First Posted
April 2, 2019
Study Start
November 25, 2019
Primary Completion
December 14, 2019
Study Completion
December 14, 2019
Last Updated
April 7, 2020
Record last verified: 2020-04